 The FDA oftentimes will allow a pharmaceutical company to only perform what we call one pivotal or phase three trial. That's the final clinical trial that's done before the FDA approval. Whereas in transplantation, historically, they have asked for two pivotal or phase three trials. And each of those trials not only takes many years to complete, but also take about $100 million in order to support the conduct of that trial.